US Stocks
/
Kymera Therapeutics, Inc. Share Price
Kymera Therapeutics, Inc. Share Price

Kymera Therapeutics, Inc. Share Price

NASDAQ: KYMR | Mid Cap
$113.97
+$5.13 (4.71%) Last updated on 10 Oct, 2026 | 00:42 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kymera Therapeutics, Inc. Stock Performance

Open
$108.64
Prev. Close
$108.84
Circuit Range
N/A
Day Range
$108.64 - $115.58
Year Range
$55.30 - $129.83
Volume
52,607
Average Traded
$113.61

Kymera Therapeutics, Inc. Share Price Today

As of 10 October 2026, Kymera Therapeutics, Inc.'s share price is $113.97. The stock opened at $108.64, compared to its previous close of $108.84. During today's trading session, Kymera Therapeutics, Inc.'s share price traded between $108.64 and $115.58, with an average price of $112.11. Over the past 52 weeks, the stock has recorded a high of $129.83 and a low of $55.30. In terms of performance, Kymera Therapeutics, Inc.'s share price has risen by 40.58% over the last six months and is up 84.21% on a year-on-year basis.

Kymera Therapeutics, Inc. Share Price Chart

$108.64$115.58
L
Show Current Price
H

Kymera Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.63B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.60
Revenue (TTM)
$39.21B
Return On Equity (TTM)
-19.85%
Profit Margin
-794.06%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
25.52%

Kymera Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.76$2.87$34.37$65.00
Net Profit-$82.18-$86.98-$69.23-$61.21
Net Profit Margin-2977.54%-3030.66%-201.43%-94.17%
Income ChangeN/A-5.84%20.41%11.58%

Kymera Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$46.83$78.59$47.07$39.21
Net Profit-$154.81-$146.96-$223.86-$311.35
Net Profit Margin-330.58%-187.00%-475.59%-794.06%
Income ChangeN/A5.07%-52.33%-39.08%

About Kymera Therapeutics, Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Kymera Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$111.47
$113.96
+1.61%
Sep 2026
$117.02
$112.15
-6.64%
Aug 2026
$100.86
$120.13
+16.28%
Jul 2026
$114.11
$103.31
-9.96%
Jun 2026
$80.66
$114.74
+40.88%
May 2026
$80.78
$81.44
+0.46%
Apr 2026
$84.45
$81.07
-2.68%
Mar 2026
$90.05
$83.31
-8.84%
Feb 2026
$71.60
$91.38
+25.71%
Jan 2026
$77.83
$72.69
-6.48%
Dec 2025
$66.75
$77.73
+14.49%
Nov 2025
$62.99
$67.89
+9.73%

KYMR Share Price FAQs

What is Kymera Therapeutics, Inc. share price today?

chevron-up
Kymera Therapeutics, Inc. share price today is $113.97 as on October 10, 2026 at 12:42 am IST.

What is the 52 week high and 52 week low of Kymera Therapeutics, Inc. stock?

chevron-up
The 52 week high of Kymera Therapeutics, Inc. stock is $129.83, while the 52 week low is $55.30 as of 10 Oct '26.

What is KYMR's market capitalisation today?

chevron-up
KYMR market capitalisation is $9.63B as of October 10, 2026, at 12:42 am IST.

What is KYMR's net income for the last quarter?

chevron-up
KYMR's net income for the last quarter is -61.21B USD.

What is the 5 year returns of KYMR?

chevron-up
The 5 year returns of KYMR is 93.56% as on 10 Oct '26.

What is the high & low stock price of KYMR today?

chevron-up
KYMR stock price hit a high of $115.58 and low of $108.64 as of 10 Oct '26.

Can I buy KYMR shares in India?

chevron-up
Yes. You can buy KYMR in India by opening an international trading account.